Rapport Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $27M | 867k | 31.30 |
| 2025-12-31 | $27M | 882k | 30.34 |
| 2025-09-30 | $33M | 1.1M | 29.70 |
| 2025-06-30 | $17M | 1.5M | 11.37 |
| 2025-03-31 | $11M | 1.1M | 10.03 |
| 2024-12-31 | $20M | 1.1M | 17.74 |
| 2024-09-30 | $22M | 1.0M | 20.48 |
| 2024-06-30 | $32M | 1.4M | 23.26 |